BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 21458900)

  • 1. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.
    Nauta FL; Bakker SJ; van Oeveren W; Navis G; van der Heide JJ; van Goor H; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2011 May; 57(5):733-43. PubMed ID: 21458900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting kidney transplantation outcomes using proteinuria ascertained from spot urine samples versus timed urine collections.
    Talreja H; Akbari A; White CA; Ramsay TO; Hiremath S; Knoll G
    Am J Kidney Dis; 2014 Dec; 64(6):962-8. PubMed ID: 25304983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine liver-type fatty acid-binding protein predicts graft outcome up to 2 years after kidney transplantation.
    Yang J; Choi HM; Seo MY; Lee JY; Kim K; Jun H; Jung CW; Park KT; Kim MG; Jo SK; Cho W; Kim HK
    Transplant Proc; 2014; 46(2):376-80. PubMed ID: 24655967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.
    Doi K; Negishi K; Ishizu T; Katagiri D; Fujita T; Matsubara T; Yahagi N; Sugaya T; Noiri E
    Crit Care Med; 2011 Nov; 39(11):2464-9. PubMed ID: 21705884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion rates of multiple renal indicators after kidney transplantation: clinical significance for early graft outcome.
    Matteucci E; Carmellini M; Bertoni C; Boldrini E; Mosca F; Giampietro O
    Ren Fail; 1998 Mar; 20(2):325-30. PubMed ID: 9574459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients.
    van Timmeren MM; Vaidya VS; van Ree RM; Oterdoom LH; de Vries AP; Gans RO; van Goor H; Stegeman CA; Bonventre JV; Bakker SJ
    Transplantation; 2007 Dec; 84(12):1625-30. PubMed ID: 18165774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial.
    Franz S; Regeniter A; Hopfer H; Mihatsch M; Dickenmann M
    Am J Kidney Dis; 2010 Feb; 55(2):335-43. PubMed ID: 19926370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of patterns of proteinuria on renal allograft function and survival: a prospective cohort study.
    Suhail SM; Kee TS; Woo KT; Tan HK; Yang WS; Chan CM; Foo MW; Li HH; Siddique MM; Wong KS
    Clin Transplant; 2011; 25(3):E297-303. PubMed ID: 21362048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant nuclear renal scans correlate with renal injury biomarkers and early allograft outcomes.
    Obeidat MA; Luyckx VA; Grebe SO; Jhangri GS; Maguire C; Zavodni A; Jackson S; Mueller TF
    Nephrol Dial Transplant; 2011 Sep; 26(9):3038-45. PubMed ID: 21321005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The independent association between serum uric acid and graft outcomes after kidney transplantation.
    Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
    Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression and outcomes in type 1 diabetic kidney transplant recipients based on posttransplantation CKD staging.
    Smavatkul C; Pascual J; Desai AG; Samaniego M; Becker BN; Djamali A
    Am J Kidney Dis; 2007 Oct; 50(4):631-40. PubMed ID: 17900463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early association of low-grade albuminuria and allograft dysfunction predicts renal transplant outcomes.
    Hernández D; Pérez G; Marrero D; Porrini E; Rufino M; González-Posada JM; Delgado P; Torres A
    Transplantation; 2012 Feb; 93(3):297-303. PubMed ID: 22228419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratifying risk in chronic kidney disease: an observational study of UK guidelines for measuring total proteinuria and albuminuria.
    Methven S; Traynor JP; Hair MD; St J O'Reilly D; Deighan CJ; MacGregor MS
    QJM; 2011 Aug; 104(8):663-70. PubMed ID: 21382924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: a 3-year posttransplantation follow-up.
    Roos M; Heinemann FM; Lindemann M; Horn PA; Lutz J; Stock K; Thürmel K; Baumann M; Witzke O; Heemann U
    Kidney Blood Press Res; 2011; 34(5):328-33. PubMed ID: 21613794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C and albuminuria as predictors of long-term allograft outcomes in kidney transplant recipients.
    Rodrigo E; Ruiz JC; Fernández-Fresnedo G; Fernández MD; Piñera C; Palomar R; Monfá E; Gómez-Alamillo C; Arias M
    Clin Transplant; 2013; 27(2):E177-83. PubMed ID: 23373671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
    J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients.
    Oterdoom LH; van Ree RM; de Vries AP; Gansevoort RT; Schouten JP; van Son WJ; Homan van der Heide JJ; Navis G; de Jong PE; Gans RO; Bakker SJ
    Transplantation; 2008 Aug; 86(3):391-8. PubMed ID: 18698241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.
    Teppo AM; Törnroth T; Honkanen E; Grönhagen-Riska C
    Transplantation; 2003 Jun; 75(12):2113-9. PubMed ID: 12829921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.